stat 13, intro. to statistical methods for the life and health ...frederic/13/f17/13day08.pdfmean...

34
Stat 13, Intro. to Statistical Methods for the Life and Health Sciences. 1. Observational studies and experiments. 2. Experiments and aspirin example. 3. Random sampling, random assignment, and blocking. 4. Blinding. 5. Portacaval shunt example. 6. Coverage, non-response bias, adherer bias, and clofibrate example. 7. More about confounding factors. Finish reading chapter 4. http://www.stat.ucla.edu/~frederic/13/F17 . HW3 is due Tue Nov 7. 4.CE.10, 5.3.28, 6.1.17, and 6.3.14. In 5.3.28d, use the theory-based formula. You do not need to use an applet. The midterm is Tue Nov 7. There is no lecture Thu Nov 9. 1

Upload: others

Post on 19-May-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Stat 13, Intro. to Statistical Methods for the Life and Health Sciences.

1. Observational studies and experiments. 2. Experiments and aspirin example. 3. Random sampling, random assignment, and blocking. 4. Blinding. 5. Portacaval shunt example. 6. Coverage, non-response bias, adherer bias, and clofibrate example. 7. More about confounding factors.

Finish reading chapter 4. http://www.stat.ucla.edu/~frederic/13/F17 .HW3 is due Tue Nov 7. 4.CE.10, 5.3.28, 6.1.17, and 6.3.14. In 5.3.28d, use the theory-based formula. You do not need to use an applet.The midterm is Tue Nov 7. There is no lecture Thu Nov 9.

1

Page 2: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

HW3 is due Tue Nov 7. 4.CE.10, 5.3.28, 6.1.17, and 6.3.14.

4.CE.10 starts out "Studies have shown that children in the U.S. who have been spanked have a significantly lower IQ score on average...."

5.3.28 starts out "Recall the data from the Physicians' Health Study: Of the 11,034 physicians who took the placebo ...."

6.1.17 starts out "The graph below displays the distribution of word lengths ...."

6.3.14 starts out "In an article titled 'Unilateral Nostril Breathing Influences Lateralized Cognitive Performance' that appeared ...."

2

Page 3: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

1. ObservationalstudiesversusExperiments

Section4.2

Page 4: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

ObservationalStudiesvs.Experiments

• Inanobservationalstudy,thesubjectsthemselvesdecidetheirleveloftheexplanatoryvariable.• Forexample,theresearchersdidn’tcontrolwhichchildrensleptwithanightlightonornot.• Observationalstudiesalwayshavepotentialconfoundingvariablespresentandthesemaypreventusfromdeterminingcauseandeffect.

Page 5: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Nightlightsandnear-sightedness

• Couldparents’eyesightbeanotherexplanation?• Maybeparentswithpooreyesighttendtousemorelighttomakeiteasiertonavigatetheroomatnightandparentswithpooreyesightalsotendtohavechildrenwithpooreyesight.• Nowwehaveathirdvariableofparents’eyesight• Parents’eyesightisconsideredaconfoundingvariable.• Otherpossibleconfounders?Wealth?Books?Computers?

Page 6: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

ConfoundingVariables• Aconfoundingvariableisassociatedwithboththeexplanatoryvariableandtheresponsevariable.• Wesayitisconfoundingbecauseitseffectsontheresponsecannotbeseparatedfromthoseoftheexplanatoryvariable.• Becauseofthis,wecan’tdrawcauseandeffectconclusionswhenconfoundingvariablesarepresent.

Page 7: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

ConfoundingVariables• Sinceconfoundingvariablescanbepresentinobservationalstudies,wecan neverconcludecausationfromasingleobservationalstudy.• Thisdoesn’tmeantheexplanatoryvariableisn’tinfluencingtheresponsevariable.Associationmaynotimplycausation,butcanbeaprettybighint.• SometimesthroughaseriesofcarefullydoneobservationalstudieseveryplausibleconfounderhasbeenaccountedforandthenpeopleconcludeXcausesY.Butitisneverasconclusiveaswithexperimentalresults.•

Page 8: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

2.Experimentsandaspirinexample.

• Inanexperiment,theresearcherssettheleveloftheexplanatoryvariableforeachsubject.• Theselevelsmaycorrespondtoatreatmentandcontrol.• Welldesignedexperimentscancontrolforconfoundingvariablesbymakingthetreatmentandcontrolgroupssimilarexceptforwhattheexperimentermanipulates.

Page 9: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Aspirinexample.

Physicians’HealthStudyI (studyaspirin’saffectonreducingheartattacks.

• Startedin1982with22,071malephysicians.

• Thephysicianswererandomlyassignedintooneoftwogroups.

• Halftooka325mgaspirineveryotherdayandhalftookaplacebo.

Page 10: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Results• Intendedtogountil1995,theaspirinstudywasstoppedin1988afterfindingsignificantresults.• 189(1.7%)heartattacksoccurredintheplacebogroupand104(0.9%)intheaspiringroup.(45%reductioninheartattacksfortheaspiringroup.)• Whataboutconfoundingvariables?Couldtheaspiringroupbedifferentthantheplacebogroupinsomeotherways?• Didtheyhaveabetterdiet?• Didtheyexercisemore?• Weretheygeneticallylesslikelytohaveheartattacks?• Weretheyyounger?

Page 11: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

TheBigIdea• Confoundingvariablesareoftencircumventedinexperimentsduetotherandomassignmentofsubjectstotreatmentgroups.• Randomlyassigningpeopletogroupstendstobalanceoutallothervariablesbetweenthegroups.• Soconfoundingvariables,includingonestheresearchersdidn'tanticipate,shouldberoughlyequalizedbetweenthetwogroupsandthereforeshouldnotbeconfounding.• Thus,causeandeffectconclusionsaresometimespossibleinexperimentsthroughrandomassignment.

Page 12: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Randomsamplingandrandomassignment.• Withobservationalstudiesorexperiments,randomsamplingisoftendone.Thispossiblyallowsustomakeinferencesfromthesampletothepopulationwherethesamplewasdrawn.• Withexperiments,randomassignmentisdone.Thispossibleallowsustoconcludecausation.

Page 13: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

• ThePhysician’sHealthStudyusedrandomassignment.Diditalsouserandomsampling?• No,hardlyanyexperimentsuserandomsampling,butgettheirsubjectsinotherways.• ThePhysician’sHealthStudysentoutinvitationlettersandquestionnairestoall261,248malephysiciansbetween40and84yearsofagewholivedintheUnitedStates.• Ofthe59,285whowerewillingtoparticipateinthetrial,26,062weretoldtheycouldnotbecauseofsomemedicalconditionorcurrentmedicaltreatment.• So,itisquestionnable towhatpopulationwecangeneralizetheresultthataspirinhelpsreducetheriskofheartattacks.

Page 14: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

ArticleBaselineDemographicsAfterRandomAssignment

Parameter Placebo(n=129)

Uceris(n=128)

Meanage,years(range) 39.9(12–68) 37.6(13–66)Men 77(59.7) 70(54.7)Women 52(40.3) 58(45.3)Meandiseaseduration(yrs) 6.3 5.5Duration≤1 year,n(%) 23(17.8) 28(21.9)Duration>5 years,n(%) 51(39.5) 44(34.4)Proctosigmoiditis 64(49.6) 58(45.3)Left-sidedcolitis 44(34.1) 37(28.9)MeanbaselineUCDAIscore 6.2 6.5MeanbaselineEIscore 6.6 6.5Priormesalazine use 75(58.1) 66(51.6)Priorsulfasalazineuse 28(21.7) 33(25.8)

Sandborn WJ,TravisS,MoroL,JonesR,Gautille T,Bagin R,HuangM,YeungP,BallardED2nd Once-dailybudesonideMMX®extended-releasetabletsinduceremissioninpatientswithmildtomoderateulcerativecolitis:resultsfromtheCOREIstudy. Gastroenterology 2012Nov;143(5):1218-26

Page 15: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

BlockingandRandomAssignment• Thegoalinrandomassignmentistomakethetwogroupsassimilaraspossibleinallwaysotherthanthetreatment.• Sometimethereareknownconfoundersandyoucanblockon(controlfor)thesevariables.• Forexample,ifoursubjectsconsistof60%femalesand40%males,wecanforcethetreatmentandcontrolgroupstobe60%femaleand40%male,usingamatchedpairdesign.• Blockingmakessensewhenthereareknownconfoundersyouwanttocontrolfor.Butrandomassignmentmakesthemsimilarevenintermsofunknownconfounders.

Page 16: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

3.Blinding.Eveninexperiments,thetreatmentandcontrolgroupscanbedifferentinwaysotherthantheexplanatoryvariable.Thisisespeciallytruewhentheresponsevariableissomewhatsubjective.Painisanexample.Onestudyfoundthat1/4ofpatientssufferingfrompost-operativepain,whengivenaplacebo(justapillofsugarandwater)claimedtheyexperienced"significantpromptpainrelief".

Page 17: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

3.Blinding.Peoplemightnotbeabletojudgetheirownlevelsofpainverywell,andmaybeinfluencedbythebeliefthattheyhavetakenaneffectivetreatment.Thusinanexperimentwithsucharesponsevariable,researchersshouldensurethesubjectdoesnotknowwhetherheorshereceivedthetreatmentorthecontrol.Thisiscalledblinding.Inadouble-blind experiment,neitherthesubjectnortheresearcherrecordingtheresponsevariableknowstheleveloftheexplanatoryvariableforeachsubject(i.e.treatmentorcontrol).

Page 18: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

4.Portacaval shuntexample.Thefollowingexampleshowstheimportanceofdoingarandomizedcontrolledexperiment.Theportacaval shuntisamedicalprocedureaimedatcurbingbleedingtodeathinpatientswithcirrhosisoftheliver.Thefollowingtablesummarizes51studiesontheportacaval shunt.Thepoorlydesignedstudieswereveryenthusiasticaboutthesurgery,whilethecarefullydesignedstudiesprovethatthesurgeryislargelyineffective.

DegreeofenthusiasmDesign High Moderate NoneNocontrols 24 7 1Controls,butnotrandomized 10 3 2Randomizedcontrolled 0 1 3

Page 19: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

4.Portacaval shuntexample.Whydidthepoorlydesignedstudiescometothewrongconclusion?Alikelyexplanationisthatinthestudieswherepatientswerenotrandomlyassignedtothetreatmentorcontrolgroup,byandlargethehealthierpatientsweregiventhesurgery.Thisalonecouldexplainwhythetreatmentgroupoutlivedthecontrolgroupinthesestudies.

DegreeofenthusiasmDesign High Moderate NoneNocontrols 24 7 1Controls,butnotrandomized 10 3 2Randomizedcontrolled 0 1 3

Page 20: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

5.Moreproblemswithstudies,andClofibrateexample.

Surveysareobservational.• Coverageisacommonissue.Coverageistheextenttowhichthepeopleyousampledfromrepresenttheoverallpopulation.Asurveyatafancyresearchhospitalinawealthyneighborhoodmayyieldpatiencewithhigherincomes,highereducation,etc.• Non-responsebiasisanothercommonproblem.Poorcoveragemeansthepeoplegettingthesurveydonotrepresentthegeneralpopulation.Non-responsebiasmeansthatoutofthepeopleyougavethesurveyto,thepeopleactuallyfillingitoutandsubmittingitaredifferentfromthepeoplewhodidnot.• Sameexactissuesinwebsurveys.

Page 21: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

5.Moreproblemswithstudies,andClofibrateexample.

Non-responsebiasissimilartoadhererbias,inexperiments.Adrugcalledclofibrate wastestedon3,892middle-agedmenwithhearttrouble.Itwassupposedtopreventheartattacks.1,103assignedatrandomtotakeclofibrate,2,789toplacebo(lactose)group.Subjectswerefollowedfor5years.Isthisanexperimentoranobservationalstudy?

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

Page 22: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

5.Moreproblemswithstudies,andClofibrateexample.

Non-responsebiasissimilartoadhererbias,inexperiments.Adrugcalledclofibrate wastestedon3,892middle-agedmenwithhearttrouble.Itwassupposedtopreventheartattacks.1,103assignedatrandomtotakeclofibrate,2,789toplacebo(lactose)group.Subjectswerefollowedfor5years.Isthisanexperimentoranobservationalstudy?

Itisanexperiment.DoesClofibrate work?Clofibrate patientswhodiedduringfollowup

adherers 15%non-adherers 25%total 20%

Page 23: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

--------------------------------------------------------------------------Placebo

adherers 15%nonadherers 28%total 21%

Thosewhotookclofibrate didmuchbetterthanthosewhodidn'tkeeptakingclofibrate.Doesthismeanclofibrate works?

Page 24: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

--------------------------------------------------------------------------Placebo

adherers 15%nonadherers 28%total 21%

Thosewhoadheredtoplaceboalsodidmuchbetterthanthosewhostoppedadhering.

Page 25: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

--------------------------------------------------------------------------Placebo

adherers 15%nonadherers 28%total 21%

Allinalltherewaslittledifferencebetweenthetwogroups.

Page 26: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

--------------------------------------------------------------------------Placebo

adherers 15%nonadherers 28%total 21%

Adherersdidbetterthannon-adherers,notbecauseofclofibrate,butbecausetheywerehealthieringeneral.Why?

Page 27: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

Clofibrate patientswhodiedduringfollowupadherers 15%non-adherers 25%total 20%

--------------------------------------------------------------------------Placebo

adherers 15%nonadherers 28%total 21%

Adherersdidbetterthannon-adherers,notbecauseofclofibrate,butbecausetheywerehealthieringeneral.Why?• adherersarethetypetoengageinhealthierbehavior.• sickpatientsarelesslikelytoadhere.

Page 28: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Byaconfoundingfactor,wemeananalternativeexplanationthatcouldexplaintheapparentrelationshipbetweenthetwovariables,eveniftheyarenotcausallyrelated.Typicallythisisdonebyfindinganotherdifferencebetweenthetreatmentandcontrolgroup.Forinstance,differentstudieshaveexaminedsmokersandnon-smokersandhavefoundthatsmokershavehigherratesoflivercancer.Oneexplanationwouldbethatsmokingcauseslivercancer.Butisthereanyother,alternativeexplanation?• Onealternativewouldbethatthesmokerstendtodrinkmorealcohol,anditisthealcohol,notthesmoking,thatcauseslivercancer.

Page 29: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Anotherplausibleexplanationisthatthesmokersareprobablyolderonaveragethanthenon-smokers,andolderpeoplearemoreatriskforallsortsofcancerthanyoungerpeople.• Anothermightbethatsmokersengageinotherunhealthyactivitiesmorethannon-smokers.• Notethatifonesaidthat“smokingmakesyouwanttodrinkalcoholwhichcauseslivercancer,”thatwouldnotbeavalidconfoundingfactor,sinceinthatexplanation,smokingeffectiveiscausallyrelatedtolivercancerrisk.

Page 30: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Aconfoundingfactormustbeplausiblylinkedtoboththeexplanatoryandresponsevariables.Soforinstancesaying“perhapsahigherproportionofthesmokersaremen”wouldnotbeaveryconvincingconfoundingfactor,unlessyouhavesomereasontothinkgenderisstronglylinkedtolivercancer.• Anotherexample:left-handednessandageatdeath.PsychologistsDianeHalpernandStanleyCoren lookedat1,000deathrecordsofthosewhodiedinSouthernCaliforniainthelate1980sandearly1990sandcontactedrelativestoseeifthedeceasedwererighthanded orlefthanded.Theyfoundthattheaverageagesatdeathofthelefthanded was66,andfortherighthanded itwas75.Theirresultswerepublishedinprestigiousscientificjournals,NatureandtheNewEnglandJournalofMedicine.

Page 31: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.Allsortsofcausalconclusionsweremadeabouthowthisshowsthatthestressofbeinglefthanded inourrighthanded worldleadstoprematuredeath.

Page 32: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Isthisanobservationalstudyoranexperiment?

Page 33: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Isthisanobservationalstudyoranexperiment?Itisanobservationalstudy.• Arethereplausibleconfoundingfactorsyoucanthinkof?

Page 34: Stat 13, Intro. to Statistical Methods for the Life and Health ...frederic/13/F17/13day08.pdfMean baseline UCDAI score 6.2 6.5 Mean baseline EI score 6.6 6.5 Prior mesalazine use 75

6.Moreaboutconfoundingfactors.• Aconfoundingfactoristheageofthetwopopulationsingeneral.Leftiesinthe1980swereonaverageyoungerthanrighties.Manyoldleftieswereconvertedtorightiesatinfancy,intheearly20thcentury,butthispracticehassubsided.Thusinthe1980sand1990s,therewererelativelyfewoldleftiesbutmanyyoungleftiesintheoverallpopulation.Thisaloneexplainsthediscrepancy.